Efficacy of Fluocinolone Acetonide Intravitreal Implant in Diabetic Macular Edema
Completed
Bausch & Lomb Incorporated
Phase 2/Phase 3
2001-09-01
This was a multi-center, randomized, masked, parallel-group, controlled study in patients
with diabetic macular edema, comparing RetisertTM (0.59 mg) with control therapy (standard of
care (SOC) - repeat macular grid laser or observation). The objective was to evaluate the
safety and efficacy of the intravitreal fluocinolone acetonide implant in the treatment of
patients with diabetic macular edema.
Re-implantation of a Fluocinolone Acetonide Implant for Non-infectious Uveitis Affecting the Posterior Segment
Completed
Bausch & Lomb Incorporated
Phase 4
2004-03-01
The purpose of this study is to collect data on patients with severe uveitis that have
required re-implantation of the sustained-release fluocinolone drug delivery device due to
depletion of study drug in their previous implanted device.
Re-implantation of a Fluocinolone Acetonide Implant for Non-infectious Uveitis Affecting the Posterior Segment
Completed
Duke University
Phase 4
2004-03-01
The purpose of this study is to collect data on patients with severe uveitis that have
required re-implantation of the sustained-release fluocinolone drug delivery device due to
depletion of study drug in their previous implanted device.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
